Navigation Links
Caliper Life Sciences Launches IVIS(R) In Vivo Imaging System with X-Ray
Date:9/14/2009

HOPKINTON, Mass., Sept. 14 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, today introduced the IVIS Lumina XR in vivo imaging system, the latest addition to the IVIS product family. The Lumina XR system combines highly sensitive bioluminescence and fluorescence molecular optical imaging with the anatomical precision of digital x-ray. Integrating these three imaging modalities provides researchers with additional capabilities to explore the molecular basis of disease and determine the response to drug therapies.

Caliper's non-invasive IVIS preclinical molecular optical imaging technology is an innovative research tool that has greatly advanced both basic scientific research as well as the novel breakthrough research necessary to develop safe new drugs. To date, peer-reviewed publications show that IVIS technology has aided the discovery and development of five FDA-approved therapies and more than nine drug compounds in development. The introduction of the Lumina XR system takes this innovation one step further by combining optical fluorescent and bioluminescent images of biological activity with co-registered digital x-ray images, enhancing the anatomical context of the optical molecular signals. For example, with x-ray co-registration the researcher can view a detailed image of the skeleton, or even certain soft tissues, and can use those images as a reference point when using bioluminescence to more precisely locate a tumor or infection site in an animal.

"Caliper's bioluminescent and fluorescent IVIS imaging systems are well recognized by researchers at top universities and pharmaceutical companies as the leading pre-clinical in vivo imaging solution," said Kevin Hrusovsky, president and chief executive officer, Caliper Life Sciences. "The demand for advanced preclinical imaging technologies continues to increase, and Caliper is meeting that demand by offering a multimodality solution that will enhance current research applications and further enable newer areas of research, including bone disease and arthritis. We remain committed to providing scientists with valuable tools that translate experimentation into viable clinical options."

All IVIS systems are optically capable of imaging the full spectrum of fluorescent and bioluminescent reporters and dyes, from green to near-infrared, with quantitative results and high performance spectral unmixing, to extract maximum information from animal models. Lumina XR can incorporate the premium animal handling features of Caliper's other IVIS imaging systems, such as a heated stage, gas anesthesia connections and a syringe injection system for simultaneous compound administration. In addition to mice, the Lumina XR can accommodate Petri dishes or micro-titer plates for in vitro imaging. And like Caliper's other IVIS imaging systems, the Lumina XR will serve a broad array of therapeutic areas, including cancer research, infectious disease, inflammation, metabolic disease, neurology, cardiovascular disease, toxicology and other applications.

For additional information on Caliper's portfolio of optical imaging systems, please visit http://www.caliperls.com/products/optical-imaging .

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.

Caliper and IVIS are registered trademarks of Caliper Life Sciences, Inc.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Caliper Life Sciences Reports Second Quarter 2009 Results
2. Caliper Life Sciences Second Quarter 2009 Financial Results Conference Call Notice
3. Caliper Life Sciences Introduces Staccato Protein Workstation for Automated Protein Sample Preparation & Analysis
4. Caliper Life Sciences to Webcast Investor Session of Open House
5. Caliper Life Sciences Reports First Quarter 2009 Results
6. Caliper Life Sciences Announces Date and Location of its 2009 Annual Meeting of Stockholders
7. EPA Presents Initial Results from Caliper Life Sciences ToxCast Screening Effort
8. Caliper Life Sciences Reports Fourth Quarter and Full Year 2008 Results
9. Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling
10. Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
11. Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... 2017 Personal Genome Diagnostics Inc. (PGDx) today announced ... Association for Cancer Research (AACR) Annual Meeting 2017, being held ... The company also announced that five scientists associated with PGDx—two ... Annual AACR Team Science Award. ... Doug Ward , CEO ...
(Date:3/29/2017)... Maryland , and HILDEN, Germany , March 29, 2017 ... FRANKFURT PRIME STANDARD: QIA) today announced the U.S. launch ... JAK2 assay), which was cleared by the U.S. Food and Drug Administration ... V617F/G1849T allele in genomic DNA extracted from EDTA whole blood.* ... The ipsogen JAK2 assay is processed on QIAGEN,s ...
(Date:3/29/2017)... ... 2017 , ... (March 29, 2017) — Nerium International ... an active member of the Mexican Direct Selling Association A.C. (AMVD ). ... relationship marketing. This professional organization fosters loyal and fair competition among companies within ...
(Date:3/29/2017)... ... March 29, 2017 , ... ACEA Biosciences, a ... a quarterly travel award to noteworthy scientists who will be presenting research using ... new round of awards are being given to two postdoctoral fellows studying pathogen ...
Breaking Biology Technology:
(Date:3/20/2017)... March 20, 2017 At this year,s CeBIT Chancellor ... biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together with ... this year,s CeBIT partner country. At the largest German biometrics company the ... fingerprint, face and iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/9/2017)... FRANCISCO and MOUNTAIN VIEW, Calif. ... , "Eating Well Made Simple," and 23andMe , ... help guide better food choices.  Zipongo can now provide ... their food preferences, health goals and biometrics, but also ... certain food choices. Zipongo,s personalized food decision ...
(Date:3/2/2017)... , March 2, 2017 Summary ... better understand Merck KGaA and its partnering interests and ... https://www.reportbuyer.com/product/3605601/ Description The Partnering Deals and Alliance ... partnering activity of one of the world,s leading life ... prepared upon purchase to ensure inclusion of the most ...
Breaking Biology News(10 mins):